Skip to navigation (Press Enter)
Skip to main content (Press Enter)
Get A Quote
Container Closure Integrity Testing
--Sign Up For Newsletter
--Method Development And Validation
--Personal Care Chemistry Testing
--Anaytical Gas Testing
--CONTAINER CLOSURE INTEGRITY
--Vacuum Decay Leak Detection
--Electrical Conductivity (HVLD)
--Helium Leak Testing (HeLD)
--Residual Seal Force (RSF)
--Mass Flow Leak Detection
--USP 660 Pharmaceutical Glass Testing
--USP 661 Plastic Containers Testing
--USP 670 Auxiliary Packaging Components
--USP 671 Container Performance Testing
--EP & JP Container Testing
--Elastomeric Closure Testing
--Biological Reactivity Testing
--Container Qualification Full Test List
--Drug Delivery Device Testing
--Dose Delivery Testing
--Mechanical and Functional Testing
--Extractables and Leachables
--E&L for Pharma/Biotech
--Medical Device Testing
--ISO 10993 Biocompatibility
--ISO 11607 Validation
--Device Mechanical and Functional
--Microbial Limits Test
--Bacterial Endotoxin Testing: USP <85>
--Antimicrobial Effectiveness Testing (AET)
--USP<87> Biological Reactivity Tests – In-Vitro
--Disinfectant Efficacy Testing
--DISTRIBUTION AND PACKAGE TESTING
--ASTM & ISTA Distribution Testing
--Environmental Cycling And Simulation Testing
--Pharmacuetical Package Testing
--Medical Device Packaging Testing
--Consumer Product Testing
--Shelf Life & Accelerated Aging Testing
--Packaging Materials Testing
--Package Integrity Testing
--Package Strength Testing
--Package Labeling Testing
--Retains and Complaint Resolution
The Accumulative Effect Of The Transport Environment (Part 6)
In package performance protocols, these vibration forces are incorporated into a regimen of other transport hazards such as handling (shock), compression, and environmental temperature and humidity extremes.
Part 5 - Vibration Testing - What test to Use?
ASTM D 4169-14 is the current FDA approved consensus standard. The typical test regimen for medical device package testing is distribution cycle 13 (DC 13). The test intensity levels are most co
Consolidating Your Vendor Network: Why It Is Important To Work With A Laboratory That Offers A Range Of Services
Whitehouse Laboratories is one such location that provides all of the testing and validation services that any medical or pharmaceutical manufacturer needs to ensure the efficacy of their products, and the safe delivery to their end use.
What may cause difficulty for MDM’s in vibration testing and performance testing programs
The debate in the industry is which standard to use for compliance with the ISO 11607 standard.
Medical Device Package Performance - Vibration Testing (Part 3)
Significant product and package responses and interactions during shipment can be severe and may lead to package or product failure. Identification of critical frequencies and the nature of package stresses can aid in minimizing the effect of these occurrences.
Vibration Testing in the Medical Device Industry
Is critical in the package development and design process to assess the ability of the sterile barrier system to resist the vibratory forces in the transport environment
Vibration and its Damaging Effects?
The nebulous aspect of vibration is that most of the damage caused by vibration forces is not known to have occurred until the product is delivered and about to be used for its intended use.
Challenges of Microbiological Testing - Part IV - Complex Solutions
Often in the microbial examination of products, physical issues occur that force adaptations to the sample preparation. Some of these challenges include viscosity, the need for mixing or blending to a
Challenges of Microbiological Testing - Part III - Inhibitory Products
The microbiological examination of products can often prove challenging when the product is antimicrobial. This is often by design, but can also be inherent to the excipients, inherent to the active p
Challenges of Microbiological Testing: Part II - Suitability Testing
Suitability Testing is integral to any Microbiological test system. Suitability testing demonstrates that the test system and methodology are suitable for the intended purpose and compatible with the
Challenges of Microbiological Testing: Part - Controls and Validation
Controls, Validation, and Challenges of Bioburden Testing, Microbial Limits Testing, or Microbial Examination of Non-sterile products
High Voltage Leak Detection (HVLD) Testing Using The EScan 625 Instrument
In this first part of a series of blogs discussing High Voltage Leak Detection (HVLD), I will provide a general overview of one of the more popular HVLD units, an EScan 625 manufactured by PTI Inspect
Elemental Analysis from a Quality Standpoint
Quality Assurance Units must provide assurance that the validation process has produced the expected results as per the requirements of USP General Chapter <233> Elemental Impurities in accordance with <1225> Validation of compendial procedures
ASTM D4169 Distribution Simulation Testing
Let's take a moment to go into detail of one of the most widely used distribution simulation test methods, ASTM D4169 – Standard Practice for Performance Testing of Shipping Containers and Systems.
FDA Guidance on Method Validation – Part One
Method Validation effects the development and quality control testing of most products. Updated FDA guidance titled Analytical Procedures and Methods Validation for Drugs and Biologics
Assessing CCI at Ultra Low Temperatures
With the increasing utilization of ultracold frozen storage to maintain product potency, the question arises: how do we verify container closure integrity at these extremely low temperatures?
A Candid Look at the Contract Pharma Conference
A few months back I published a blog article on the value of attending Interphex. For the regular readers (I know there are few), you will recall that I started that article by simply stating my dista
Residual Solvents: Most Difficult and Demanding Test in the Pharmaceutical Industry
Pharmaceutical products should contain low levels of residual solvents as determined by safety data. The presence of residual solvents in pharmaceutical products needs to be determined through testing
Trends in CCIT Part III: The Rise of the Autoinjector
As development of biologics and biosimilars forges on, the autoinjector remains on the rise. Industry shifts to deterministic test methods translate to a need to develop and validate methods for autoinjectors
Effective Teamwork in a GMP Laboratory Environment
Three years ago, the executive management of Whitehouse Laboratories implemented a major reorganization plan. Over the previous ten years, the company had experienced many areas of growth to include e
Trends in CCIT Part II: Reactive vs Preventative CCIT Programs
CCIT programs in lifecycle of a product-package system; from development of the package, to stability, to analysis of package integrity after distribution cycles. As related to proposed revisions to USP 1207
Trends in CCIT Part I: Probabilistic to Deterministic
In the past four or so years working with clients to develop and validate container closure integrity (CCI) test methods, there have been a number overarching trends that have become readily apparent.
Navigating USP Updates
Available tools to navigate the USP flow of information that will help remain abreast of changes that may affect your organization
USP 661 Container Testing – Common Questions
Common concerns and questions regarding USP 661 Container Testing. Outline answers to ten common questions that the USP has received specific to the USP 661 chapter
The Value of Pharmaceutical, Biotechnology and Science Related Internship Programs
implementing an intern program for college students specific to engineers, chemistry, biology and material science students can lead to a mutually rewarding results
The Strategic Use of Outsourcing
Contract laboratories go beyond routine laboratory work and provide the consultancy support required to meet theses ever changing regulatory developments.
Defining Technical Services
Technical Services division performs testing in key service areas such as, Unit Dose, Mechanical Testing, Stability. Cleaning Validation, Extractable Leachable.
High Performance Liquid Chromatography (HPLC) Testing
High Performance Liquid Chromatography otherwise known as HPLC testing
The Value of Attending the Interphex Conference
Three key observations as to why Interphex is a must attend event. Interphex will bring over 12,000 global pharmaceutical and biotechnology professionals together in New York
Choosing a Distribution Test Method
In a recent article, we reviewed and discussed key concerns when selecting a test partner for package testing. Oftentimes, Life Science manufacturers struggle with packaging system development a
Qualifying “Excipient” Gases (Nitrogen, Carbon Dioxide, Oxygen) In the Drug Manufacturing Process
Qualifying Excipient Gases In the Drug Manufacturing Process. Steps to minimize and eradicate the possibility for the introduction of contaminated substances
Considerations When Choosing a Partner for Medical Device or Package Testing
In a recent article, we reviewed and discussed key components of cGMP and ISO 17025 quality systems and the role they play in the world of contract laboratory testing as it relates to pharmaceutical,
A Review of Gas Chromatography (GC) Testing
A review of the basic operation of the GC instrument for a better understanding of this commonly used test method.
The Value of ISO 17025 and cGMP Quality System Standards
Key areas to focus on when qualifying an outsourcing partner are Good Manufacturing Practices (GMP), and ISO 17025 quality standards.
An Overview of ISO 11607 Testing
Key components to the ISO 11607 procedure. ISO 11607 is the principle guidance for validating terminally sterilized medical device packaging
Are You Qualifying Your Dose Cups?
The Proper Approach to Volume Verification Testing of Metered Drug Delivery Devices
USP 671 Permeation – Clarification on Changes
Pending changes effective December 14, 2014 and insights into how industry companies may utilize the procedures to insure they meet the regulatory (FDA) requirements
Stability Testing – Overview and Update
Stability testing and monitoring in the drug development and manufacturing process. A critical step applicable to Food and Drug Administration (FDA) regulated products.
Updates on Container & Package Testing
Pending United States Pharmacopeia (USP) changes for container and package systems.
Syringe Qualification Testing
The USP 661 and USP 671 general chapters are effective in outlining the test requirements for a plastic container and a package system.
Container Qualification Testing – The Closure Dilemma
USP 661 and USP 671 general chapters. Qualification testing of a closure for a pharmaceutical use container so it meets the USP qualification process
Container Integrity Testing Part Four – Capping, Residual Seal Force & Laser Diffraction
In part three of this series on CCIT, two commonly used methods – Residual Seal Force and Laser Diffraction – will be reviewed.
Container Integrity Testing Part Three – Helium & Mass Extraction
In part three of this series on CCIT, two commonly used methods – Helium and Mass Extraction – will be reviewed.
Container Integrity Testing Part Two - Vacuum Decay and HVLD
In part two of this series on CCIT, two commonly used methods – Vacuum Decay and High Voltage Leak Detection – will be reviewed.
Part One – Current State of Container Integrity Testing
This series of articles will review the present state of Container Closure Integrity Testing, the various methods currently available, the factors for choosing the most optimal method and current regulatory guidelines under development.
Container Closure Integrity Testing (24)
Container Testing (23)
Materials Testing (17)
Package Testing (19)
Technical Services (20)